Controversies in transrectal ultrasonography and prostate biopsy

Ultrasound Quarterly

Volumn 22, Issue 3, 2006, Pages 169-175

  Sadeghi Nejad, Hossein ^a,b,c   Simmons, Marc ^c   Dakwar, George ^c   Dogra, Vikram ^d  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Prostate cancer; Prostate specific antigen; Transrectal ultrasound guided biopsy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; LIDOCAINE; PROSTATE SPECIFIC ANTIGEN;

ANESTHESIA; BLEEDING; CANCER SCREENING; CANCER TISSUE; CONTROLLED STUDY; ESOPHAGUS PRESSURE; GOLD STANDARD; HUMAN; HUMAN TISSUE; LABORATORY TEST; LOW DRUG DOSE; NEOPLASM; NERVE BLOCK; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; UROLOGY;

BIOPSY; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; MALE; NERVE BLOCK; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECTUM; TUMOR MARKERS, BIOLOGICAL;

EID: 33748618471     PISSN: 08948771     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ruq.0000226875.35184.15     Document Type: Review

References (61)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2004;54:8-29.
2. National Cancer Institute. Prostate Cancer: Screening. Bethesda, MD: National Cancer Institute; 2004.
3. American Cancer Society. American Cancer Society Guidelines 2004. Atlanta, GA: American Cancer Society; 2004.
4. Richie JP, Catalona WJ, Ahmann FR, et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology. 1993;42:365-374.
5. Schroder FH, van der Maas P, Beemsterboer P, et al. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst. 1998;90:1817-1823.
6. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med. 2004;350:2239-2246.
7. Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA. 1993;270:860-864.
8. Catalona WJ, Hudson MA, Scardino PT, et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol. 1994;152:2037-2042.
9. Morgan TO, Jacobsen SJ, McCarthy WF, et al. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med. 1996;335:304-310.
10. Smith DS, Catalona WJ. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol. 1994;152:1163-1167.
11. Singh H, Canto EI, Shariat SF, et al. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol. 2004;171:1850-1854.
12. Djavan B, Milani S, Remzi M. Prostate biopsy: who, how and when. An update. Can J Urol. 2005;12(suppl 1):44-48. discussion 99-100.
13. Patel DA, Presti JC Jr, McNeal JE, et al. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. J Clin Oncol. 2005;23:6157-6162.
14. Brawer MK, Aramburu EA, Chen GL, et al. The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol. 1993;150:369-373.
15. Matlaga BR, Eskew LA, McCullough DL. Prostate biopsy: indications and technique. J Urol. 2003;169:12-19.
16. Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA. 1998;279:1542-1547.
17. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA. 1997;277:1452-1455.
18. Pelzer AE, Volgger H, Bektic J, et al. The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels. BJU Int. 2005;96:995-998.
19. Shandera KC, Thibault GP, Deshon GE Jr. Variability in patient preparation for prostate biopsy among American urologists. Urology. 1998;52:644-646.
20. Davis M, Sofer M, Kim SS, et al. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol. 2002;167:566-570.
21. Jeon SS, Woo SH, Hyun JH, et al. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology. 2003;62:461-466.
22. Carey JM, Korman HJ. Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol. 2001;166:82-85.
23. Sieber PR, Rommel FM, Agusta VE, et al. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol. 1997;157:2199-2200.
24. Maan Z, Cutting CW, Patel U, et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int. 2003;91:798-800.
25. Herget EJ, Saliken JC, Donnelly BJ, et al. Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can Assoc Radiol J. 1999;50:173-176.
26. Ihezue CU, Smart J, Dewbury KC, et al. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol. 2005;60:459-463. discussion 457-458.
27. Issa MM, Bux S, Chun T, et al. A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. J Urol. 2000;164:397-399.
28. Mallick S, Humbert M, Braud F, et al. Local anesthesia before transrectal ultrasound guided prostate biopsy: comparison of 2 methods in a prospective, randomized clinical trial. J Urol. 2004;171:730-733.
29. Desgrandchamps F, Meria P, Irani J, et al. The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int. 1999;83:1007-1009.
30. Cevik I, Ozveri H, Dillioglugil O, et al. Lack of effect of intrarectal lidocaine for pain control during transrectal prostate biopsy: a randomized prospective study. Eur Urol. 2002;42:217-220.
31. Chang SS, Alberts G, Wells N, et al. Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective double-blind randomized trial. J Urol. 2001;166:2178-2180.
32. Nash PA, Bruce JE, Indudhara R, et al. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol. 1996;155:607-609.
33. Bulbul MA, Haddad MC, Khauli RB, et al. Periprostatic infiltration with local anesthesia during transrectal ultrasound-guided prostate biopsy is safe, simple, and effective: a pilot study. Clin Imaging. 2002;26:129-132.
34. Ozveri H, Cevik I, Dillioglugil O, et al. Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study. Prostate Cancer Prostatic Dis. 2003;6:311-314.
35. Taverna G, Maffezzini M, Benetti A, et al. A single injection of lidocaine as local anesthesia for ultrasound guided needle biopsy of the prostate. J Urol. 2002;167:222-223.
36. Lee-Elliott CE, Dundas D, Patel U. Randomized trial of lidocaine vs lidocaine/bupivacaine periprostatic injection on longitudinal pain scores after prostate biopsy. J Urol. 2004;171:247-250.
37. Stirling BN, Shockley KF, Carothers GG, et al. Comparison of local anesthesia techniques during transrectal ultrasound-guided biopsies. Urology. 2002;60:89-92.
38. Obek C, Ozkan B, Tunc B, et al. Comparison of 3 different methods of anesthesia before transrectal prostate biopsy: a prospective randomized trial. J Urol. 2004;172:502-505.
39. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142:71-74. discussion 74-75.
40. Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997;50:562-566.
41. Presti JC Jr, Chang JJ, Bhargava V, et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000;163:163-166. discussion 166-167.
42. Presti JC Jr. Prostate biopsy: how many cores are enough? Urol Oncol. 2003;21:135-140.
43. Presti JC Jr, O'Dowd GJ, Miller MC, et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol. 2003;169:125-129.
44. Bauer JJ, Zeng J, Zhang W, et al. Lateral biopsies added to the traditional sextant prostate biopsy pattern increases the detection rate of prostate cancer. Prostate Cancer Prostatic Dis. 2000;3:43-46.
45. Naughton CK, Ornstein DK, Smith DS, et al. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol. 2000;163:168-171.
46. McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12:897-906.
47. Terris MK, Pham TQ, Issa MM, et al. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol. 1997;157:204-206.
48. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 1995;154:1791-1794.
49. Park S, Shinohara K, Grossfeld GD, et al. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001;165:1409-1414.
50. Aboseif S, Shinohara K, Weidner N, et al. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995;76:355-359.
51. Brawer MK, Bigler SA, Sohlberg OE, et al. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology. 1991;38:103-107.
52. Davidson D, Bostwick DG, Qian J, et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol. 1995;154:1295-1299.
53. Garnett JE, Oyasu R. Urologic evaluation of atypical prostatic hyperplasia. Urology. 1989;34:66-69.
54. Keetch DW, Humphrey P, Stahl D, et al. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol. 1995;154:347-351.
55. Langer JE, Rovner ES, Coleman BG, et al. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol. 1996;155:228-231.
56. Markham CW. Prostatic intraepithelial neoplasia: detection and correlation with invasive cancer in fine-needle biopsy. Urology. 1989;34:57-61.
57. Raviv G, Janssen T, Zlotta AR, et al. Prostatic intraepithelial neoplasia: influence of clinical and pathological which on the detection of prostate cancer. J Urol. 1996;156:1050-1054. discussion 1054-1055.
58. Weinstein MH, Epstein JI. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol. 1993;24:624-629.
59. Lefkowitz GK, Sidhu GS, Torre P, et al. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology. 2001;58:999-1003.
60. Moore CK, Karikehalli S, Nazeer T, et al. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol. 2005;173:70-72.
61. Ozden E, Gogus C, Karamursel T, et al. Transrectal sonographic features of prostatic intraepithelial neoplasia: correlation with pathologic findings. J Clin Ultrasound. 2005;33:5-9.